1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South America Genome Editing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South America Genome Editing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South America Genome Editing Market Regional Analysis
6.2 South America Genome Editing Market Revenue 2019-2028 (US$ Million)
6.3 South America Genome Editing Market Forecast Analysis
7. South America Genome Editing Market Analysis – by Technology
7.1 CRISPR
- 7.1.1 Overview
- 7.1.2 CRISPR: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 TALEN
- 7.2.1 Overview
- 7.2.2 TALEN: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Antisense
- 7.3.1 Overview
- 7.3.2 Antisense: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. South America Genome Editing Market Analysis – by Application
8.1 Cell Line Engineering
- 8.1.1 Overview
- 8.1.2 Cell Line Engineering: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Genetic Engineering
- 8.2.1 Overview
- 8.2.2 Genetic Engineering: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Diagnostic Applications
- 8.3.1 Overview
- 8.3.2 Diagnostic Applications: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Drug Discovery
- 8.4.1 Overview
- 8.4.2 Drug Discovery: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. South America Genome Editing Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Clinical Research Organizations
- 9.3.1 Overview
- 9.3.2 Clinical Research Organizations : South America Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. South America Genome Editing Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South America Genome Editing Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 South America Genome Editing Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 Brazil: South America Genome Editing Market Breakdown, by Technology
- 10.2.1.1.2 Brazil: South America Genome Editing Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South America Genome Editing Market Breakdown, by End User
- 10.2.1.2 Argentina:
South America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Argentina: South America Genome Editing Market Breakdown, by Technology
- 10.2.1.2.2 Argentina: South America Genome Editing Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South America Genome Editing Market Breakdown, by End User
- 10.2.1.3 Rest of South and Central America :
South America Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : South America Genome Editing Market Breakdown, by Technology
- 10.2.1.3.2 Rest of South and Central America : South America Genome Editing Market Breakdown, by Application
- 10.2.1.3.3 Rest of South and Central America : South America Genome Editing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 MERCK KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Lonza
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GenScript
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 New England Biolabs
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Eurofins Scientific
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 CRISPR Therapeutics
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations